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ABSTRACT
Objective: Use of medical radiotherapy has increased
markedly in recent decades. Whether the consequence
includes an increased risk of cardiovascular disease
remains to be determined. The purpose of this study
was to examine the association between radiation
exposure and the incidence of stroke among Japanese
atomic bomb survivors.
Design: A prospective follow-up study.
Setting and participants: Radiation exposure
from the atomic bombing was assessed in 9515
subjects (34.8% men) with 24-year follow-up from
1980. Subjects were free of prevalent stroke when
follow-up began.
Outcome measures: Stroke events and the
underlying cause of death were reviewed to conﬁrm
the ﬁrst-ever stroke. Subtypes (ischaemic and
haemorrhagic events) were categorised based on
established criteria according to the deﬁnitions of
typical/atypical stroke symptoms.
Results: Overall mean radiation dose (6SD) in units
of gray (Gy) was 0.3860.58 (range: 0e3.5).
During the study period, 235 haemorrhagic and 607
ischaemic events were identiﬁed. For men, after
adjusting for age and concomitant risk factors, the
risk of haemorrhagic stroke rose consistently from
11.6 to 29.1 per 10000 person-years as doses
increased from <0.05 to $2G y( p ¼0.009).
Incidence also rose within the dose range <1G y
(p¼0.004) with no dose threshold. In women, the
risk of haemorrhagic stroke rose with increasing
radiation exposure but not until doses reached
a threshold of 1.3 Gy (95% CI 0.5 to 2.3). Among
women, for doses <1.3 Gy, differences in stroke risk
were modest (13.5 per 10000 person-years), while it
increased to 20.3 per 10000 person-years for doses
that ranged from 1.3 to <2.2 Gy and to 48.6 per
10000 person-years for doses that were higher
(p¼0.002). In both sexes, dose was unrelated to
ischaemic stroke.
Conclusion: While the risk of haemorrhagic stroke
increases with rising radiation exposure for both
sexes, effects in women are less apparent until doses
exceed a threshold at 1.3 Gy.
INTRODUCTION
Worldwide use of radiographic procedures in
medicine has increased markedly in recent
decades.
1e3 While health beneﬁts are
thought to outweigh the risk of adverse side
effects, increased use of radiotherapy,
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ARTICLE SUMMARY
Article focus
- Use of medical radiotherapy has increased in
recent decades.
- Whether the consequence includes an increased
risk of cardiovascular disease is unknown.
- Our purpose was to examine the association
between radiation exposure and the incidence of
stroke among atomic bomb survivors in Japan.
Key messages
- Risk of haemorrhagic stroke increased with
rising radiation exposure for both sexes,
although effects in women were less apparent
until doses exceeded a threshold at 1.3 Gy.
- Radiation exposure was unrelated to ischaemic
stroke.
Strengths and limitations of this study
- This report provides information on the incidence
of stroke using data from clinical examinations
and mortality records following a structured
research protocol.
- Measurement of radiation exposure adheres to
a precise system of quantiﬁcation.
- While best attempts were made to properly
classify strokes outcomes, diagnostic uncertainties
persist.
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Open Access Researchparticularly in the age range <65 years,
2 raises concerns
over the promotion of a variety of adverse health
outcomes, most notably cancer. Although equivocal, data
from patient samples and occupational studies suggest
that a corresponding rise could also occur in the inci-
dence of circulatory disease and asymptomatic athe-
rosclerosis.
4e11 Based on mail surveys and vital statistics
records from the Japanese atomic bomb survivors Life
Span Study (LSS), evidence indicates that radiation
>0.5 gray (Gy) increases the risk of all-stroke death
(1950e2003).
12 Associations that include gender effects
and stroke subtypes, however, have not been clearly
identiﬁed. Our purpose was to examine the association
between radiation and stroke incidence among atomic
bomb survivors in the Adult Health Study (AHS)
from the Radiation Effects Research Foundation
(RERF) over two decades (1980e2003). Stroke
outcomes include morbidity and mortality from
haemorrhagic and ischaemic events after adjustment for
several concomitant risk factors.
METHODS
Study population
In 1950, the Atomic Bomb Casualty Commission (now
the RERF) established the LSS of 120321 survivors of the
atomic bombings of Hiroshima and Nagasaki, Japan.
13
Follow-up is limited to periodic mail surveys and
mortality outcomes from vital statistics data. In 1958,
a series of comprehensive physical examinations was
performed with the establishment of the AHS cohort
consisting of 19961 subjects from the LSS subjects. In
the AHS, examinations have been given biennially with
informed consent and approval from the RERF Ethics
Committee. The AHS biennial health examinations
provide clinical information complementary to death
and tumour registries data. The AHS includes individ-
uals exposed to a broad range of doses to enhance
detection of radiation effects on a variety of disease
outcomes. Participation rate has ranged from 70% to
90% throughout the examination cycles. For the current
report, follow-up began at examinations that were given
in 1980. From that time, subjects were followed for
incident stroke over a 24-year period (until the end of
2003). Of the eligible 11231 participants, 208 prevalent
stroke (35 were haemorrhagic, 117 were ischaemic and
56 were of unknown origin), and 1508 without dose
information were excluded. The ﬁnal sample includes
9515 AHS participants.
Radiation dosimetry
Estimation of radiation dose exposure for each indi-
vidual was based on an updated dosimetry system (DS02)
that takes into account biases arising from errors in
calculated doses, physical locations and organ shielding
at the time of bombing.
14 For all analyses, weighted
colon doses were used in units of gray (Gy), where the
dose for an individual corresponds to the total exposure
in g rays + 103 the smaller neutron dose.
14 Colon dose
was selected a priori because of broad (systemic)
cardiovascular processes that are often associated with
stroke. This includes the major system-wide precursors
of hypertension, cigarette smoking, total cholesterol,
diabetes and body mass. Colon dose was also used in an
earlier study of circulatory disease in the RERF.
12
Stroke ascertainment
Possible stroke events and the underlying cause of death
were coded according to International Classiﬁcation of
Disease (ICD) in the RERF database. The ICD codes of
stroke-related disease are 330e332, 334, 352 and 435
(ICD-7); 333, 430e434, 436 and 438 (ICD-8); 430, 431
and 433e438 (ICD-9) and G45, I60, I61, I63e66 and I69
(exclude I698) (ICD-10). Virtually all deaths are
assumed accounted for based on access to a compre-
hensive nationwide registration of deaths in Japan. The
number of missed cases of non-fatal strokes in subjects
who remained alive at the close of follow-up (2003) is
unknown, although with high participation across
repeated AHS examinations, it is thought to be small.
There is no indication of bias in the indexing of stroke
by radiation exposure. All data (health examinations,
death certiﬁcates and autopsy reports when available)
were reviewed to conﬁrm the ﬁrst-ever stroke. Stroke was
deﬁned as an acute-onset focal neurological deﬁcit of
vascular aetiology, persisting for at least 24 h. Stroke
subtypes (ischaemic and haemorrhagic events) were
categorised based on established criteria that included
clinical features, neuroimaging and non-invasive vascular
studies, and other laboratory criteria according to the
deﬁnitions of typical/atypical stroke symptoms in the
WHO Monitoring of Trends and Determinants in
Cardiovascular Disease Projects.
15 Ischaemic stroke was
diagnosed if there was a focal neurological deﬁcit in the
absence of haemorrhage based on neuroimaging when
the neuroimage showed an ischaemic infarct that
correlated with the clinical deﬁcit or an ischaemic infarct
was documented at autopsy. Not all diagnoses of stroke
were based on neuroimaging studies. Among all strokes,
49.0% were based on death certiﬁcates alone (50.2% for
haemorrhagic stroke and 49.3% for ischaemic stroke).
Baseline examination and questionnaires
Baseline concomitant data included the age when follow-
up began, systolic blood pressure (SBP), total cholesterol
(T-CHO), body mass index (BMI), diabetes, smoking
and alcohol intake. A priori selection of these risk factors
was based on a perceived need to consider traditional
stroke risk factors, to include adjustments
16e18 that were
made in an earlier report from the RERF
12 and to
consider possible sources of confounding due to docu-
mented relationships between radiation exposure, SBP
19
and T-CHO.
20 Except for smoking and alcohol intake,
the concomitant data were collected at clinical exami-
nations that were given in 1980. In the event that an
examination cycle failed to coincide with 1980, infor-
mation from the most recent examination was used
(with 5 years). Measurement of non-fasting T-CHO is
described elsewhere.
20 Sitting SBP was measured in the
2 Takahashi I, Abbott RD, Ohshita T, et al. BMJ Open 2012;2:e000654. doi:10.1136/bmjopen-2011-000654
Stroke incidence in atomic bomb survivorsleft arm. BMI was deﬁned as weight (kg) divided by
height squared (m). A diagnosis of diabetes was based
on a physician diagnosis or the use of medications for
diabetes.
Data on smoking and alcohol intake were collected
from mail surveys that were administered from 1978 to
1980. In the absence of such data, information was taken
from direct interviews in 1965. Smoking status was
deﬁned as never-, past and current smoker. Alcohol
intake was deﬁned according to typical Japanese
consumption strata in units of ethanol as non-drinker,
light drinker (<34 g/day) and heavy drinker ($34 g/
day).
21 For the sample with interview data from 1965 and
the mail survey in 1978e1980, smoking status was
unchanged in >87% of the study participants. In
contrast, patterns of alcohol intake are more variable.
The correlation between the repeated alcohol measures
is 0.24, although it is highly signiﬁcant (p<0.001).
Statistical methods
Crude and age-adjusted incidence of haemorrhagic and
ischaemic stroke in person-years of follow-up were esti-
mated across common ranges of radiation dose based on
standard analysis of covariance methods.
22 Further
description of the procedure used in the calculation of
person-years is given elsewhere, along with its close
relationship with a Cox proportional hazards regression
model.
23 Similar methods are also useful for providing
age-adjusted percents and average levels of the
confounding risk factors across the radiation strata.
19
The primary method for testing for an independent
effect of radiation on the risk of each stroke subtype is
based on Cox proportional hazards regression models
where radiation dose is modelled as a continuous
predictor variable. Although the number of strokes is
often small (particularly haemorrhagic events), we found
no evidence for a signiﬁcant departure from the
assumption of proportionality. This assumption is
further relaxed by adjusting for age based on the use of
attained age as the time scale in the non-parametric part
of the hazard model, while radiation dose and the
concomitant risk factors were modelled as covariates in
the parametric part.
24 Concomitant risk factors included
SBP and the other risk factors. Non-linear relationships
between radiation dose and the stroke risk were also
considered, including a threshold analysis. For the latter,
dose was modelled as (D d) 3 Id(D), where D is a radi-
ation dose, d is a threshold and Id(D) ¼ 1w h e nD $d and
0 otherwise. The dose that minimises  2 3 the log
likelihood provides a point estimate for d. A 95% CI
for d consists of upper and lower threshold values for
which  2 3 the log likelihood differs from the
minimum value by 3.84 (the 95th percentile from a c
2
distribution with 1 degree of freedom). If the lower
threshold value is >0 Gy, then a dose threshold is
assumed to exist with 95% conﬁdence. Although
primary tests of signiﬁcance were based on radiation
dose being modelled as a continuous risk factor, patterns
of association are also described through the use of
indicator variables that allow for the estimation of the
relative hazard of stroke (and 95% CIs) between radia-
tion dose strata $0.05 Gy versus doses considered to be
small (<0.05 Gy). All reported p values were based on
two-sided tests of signiﬁcance. Statistical modelling and
testing were based on the use of SAS software (V.9.2; SAS
Institute Inc.).
RESULTS
Radiation exposure and study characteristics
Table 1 provides the distribution of radiation exposures,
average baseline ages and age-adjusted means and per
cent characteristics for the sample of men and women
who were available for follow-up. The average radiation
dose (6SD) for men is 0.4160.62 and for women
0.3660.55 (p<0.001). For men, 15.3% were exposed to
radiation doses $1 Gy, while 46.5% were exposed to
doses <0.05 Gy. For women, corresponding percents
were 11.6% and 44.6%.
After adjusting for differences in baseline age across
the ranges of radiation exposure, BMI declined
(although modestly) with increased radiation exposure
in men (p¼0.016) but not in women. For women, higher
radiation doses were more likely associated with elevated
SBP (p¼0.013). A similar pattern was absent in men.
While not signiﬁcant, T-CHO levels were highest in
women who had the greatest dose exposures. For the
remaining data, associations with radiation were absent.
Age-adjusted incidence of stroke by radiation exposure
During the course of follow-up, there were 235
haemorrhagic and 607 ischaemic strokes (14.0 and 36.1
per 10000 person-years, respectively). The average age at
the time of a stroke was 73.2 years (range: 43e98 years)
for those who were haemorrhagic and 77.0 years (range:
48e100 years) for those who were ischaemic. The
average follow-up time before stroke occurrence was
11.1 years (range: 3 monthse23 years) for haemorrhagic
events and 11.5 years (range: 4 dayse23 years) for
ischaemic events. There were an additional 84 strokes
that were of unknown subtype.
Table 2 provides further details on stroke incidence
that was identiﬁed according to radiation exposure at
the time of bombing. For men, after adjusting for age,
the incidence of haemorrhagic stroke rose consistently
from 12.2 to 25.2 per 10000 person-years as radiation
exposure increased from <0.05 to $2G y ( p ¼0.006).
Risk of haemorrhagic stroke continued to rise with
increasing doses <1G y ( p ¼0.006). For women, differ-
ences in the risk of haemorrhagic events were modest for
doses <2 Gy but more than tripled when doses went
higher (p¼0.002). There were no signiﬁcant relation-
ships between radiation and the risk of ischaemic events
for either sex (table 2). Relationships to total stroke were
largely determined through associations with haemor-
rhagic events. There were no relationships between
radiation and the incidence of strokes that were of
unknown origin.
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stroke and radiation exposure
The association between radiation and haemorrhagic
events was further examined after adjustment for age,
SBP, BMI, diabetes, T-CHO, cigarette smoking, alcohol
drinking and city (table 3). For men, the association was
diminished but remained signiﬁcant (p¼0.009). For
those exposed to the highest amounts of radiation
($2 Gy), there was a 2.5-fold excess risk of stroke as
compared to doses that were <0.05 Gy (29.1 vs 11.6 per
10000 person-years). Risk of haemorrhagic stroke also
rose with increasing doses <1G y( p ¼0.004), suggesting
that the doseeresponse relationship in men is not
entirely attributed to the excess of haemorrhagic events
that were observed in the highest ranges of radiation.
For women, while a doseeresponse relationship across
the entire range of radiation and the risk of haemor-
rhagic events was absent, evidence in table 2 suggests
that there may exist a threshold effect. Further analyses
identiﬁed a signiﬁcant dose threshold at 1.3 Gy (95% CI
0.5 to 2.3 Gy) where a change occurs in the association
between radiation and the risk of haemorrhagic stroke.
Below the threshold, risk was unrelated to radiation,
while above the threshold, it increased with rising dose.
This can better be seen in table 3 for dose strata <0.05,
0.05 to <1.3, 1.3 to <2.2 and $2.2 Gy. For doses <1.3 Gy,
differences in haemorrhagic risk were modest (14.2 and
13.0 per 10000 person-years), while it increased to 20.3
per 10000 person-years for doses that ranged from 1.3 to
<2.2 Gy and to 48.6 per 10000 person-years for doses
that were higher. For men, a dose threshold was absent.
In both sexes, ﬁndings do not appear to be inﬂuenced
by events that occur at an early age (<55 years).
DISCUSSION
Findings suggest that exposure to increasing radiation
doses among atomic bomb survivors beyond a threshold
of 1.3 Gy is associated with an increase in the future risk
Table 1 Distribution of radiation exposures, average baseline age and age-adjusted means and per cent characteristics for
the sample of men and women available for stroke follow-up
Characteristic
Radiation exposure (Gy)
<0.05 0.05 to <11 t o <2 ‡2
Men
Sample size 1539 1266 376 130
Per cent of sample 46.5 38.2 11.4 3.9
Baseline age* (years) 57613 57613 54613 51611
SBP (mm Hg) 135624 135623 133620 136619
T-CHO (mmol/l) 4.5360.88 4.6060.85 4.6560.96 4.5560.96
BMIy (kg/m
2) 21.963.0 21.863.0 21.762.9 21.563.0
Diabetes (%) 12.6 14.6 12.5 15.5
In Nagasaki at exposure 40.8 31.1 41.2 30.2
Smoking status (%)
Past 21.6 21.0 22.7 16.8
Current 66.6 65.6 64.2 68.5
Alcohol intake (%)
Light (<34 g/day) 44.3 42.0 42.9 44.1
Heavy ($34 g/day) 38.3 38.3 41.2 38.4
Women
Sample size 2765 2720 531 188
Per cent of sample 44.6 43.8 8.6 3.0
Baseline age* (years) 59613 60613 58612 56612
SBPz (mm Hg) 134626 135626 136625 137626
T-CHOx (mmol/l) 4.9460.91 5.0260.96 5.0961.01 5.1560.93
BMI (kg/m
2) 22.863.6 22.963.5 23.063.5 22.363.2
Diabetes (%) 6.7 8.4 8.0 7.2
In Nagasaki at exposure{ 31.0 26.5 35.7 25.8
Smoking status (%)
Past 5.1 4.3 5.3 7.2
Current 10.6 14.7 13.8 13.1
Alcohol intake (%)
Light (<34 g/day) 20.7 21.3 21.3 16.2
Heavy ($34 g/day) 0.8 1.9 1.3 0.0
Continuous variables are reported as means 6 SDs. The remaining variables are reported as per cents.
*Signiﬁcant decline with radiation exposure (p<0.001).
ySigniﬁcant decline with radiation exposure (p¼0.016).
zSigniﬁcant increase with radiation exposure (p¼0.013).
xSigniﬁcant increase with radiation exposure (p<0.001).
{Signiﬁcant increase with radiation exposure (p¼0.002).
BMI, body mass index; SBP, systolic blood pressure; T-CHO, total cholesterol.
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a point estimate, the lower 95% conﬁdence limit (0.5 to
2.3 Gy) further suggests that there is more than 95%
conﬁdence that the true threshold is 0.5 Gy or higher.
For men, the incidence of haemorrhagic stroke rose
consistently with increasing exposure levels without
evidence for a threshold. Even within the dose range
<1 Gy, the doseeresponse observed in men persisted.
The 35-year period from the time of the atomic bombing
in Hiroshima and Nagasaki to the beginning of stroke
follow-up in 1980 may be especially meaningful with
regard to the increased use of radiotherapy at younger
ages and the increased opportunity for a stroke to
develop in later life.
2
Patterns of association persisted for the period that
predated the 1980 baseline, during a time when enrol-
ment in the AHS continued to be ongoing. For the 1980
baseline used in the current report, >97% of the AHS
participants had been enrolled. The 1980 baseline also
provides a uniform beginning with a ﬁxed lag time
since the bombing of Hiroshima and Nagasaki. More
complete data from clinical examinations and a recently
conducted mail survey were also available. Although
many stroke diagnoses were based on death certiﬁcates
alone (about 50%), confounding due to changes in the
diagnosis of stroke through the advent of neuroimaging
in the late 1970s was also thought to be minimised. With
regard to the diagnostic uncertainty that is common in
any large-scale study, best attempts were made for the
proper classiﬁcation of fatal and non-fatal strokes with
the opportunity for adjudication among the study
investigators. In the absence of neuroimaging, however,
diagnostic limitations are difﬁcult to avoid. In spite of
evidence from Japanese samples that suggest that
errors in stroke classiﬁcation could be small,
25 26 subtle
distinctions between primary intracerebral haemorrhage
and ischaemic events can still exist when neuroimaging
is available.
There is also evidence of an excess risk of circulatory
disease at low and moderate doses (<5 Gy) in Japanese
atomic bomb survivors in the LSS cohort
12 where follow-
up began in 1950. Although there were no clinical
examinations in the LSS, there was a 9% excess risk of
death due to all strokes combined per unit Gy (p¼0.02).
The 5% excess RR (95%CI  6 to 17) that was observed
Table 2 Age-adjusted stroke incidence by radiation exposure
Radiation
exposure (Gy) Sample size
Haemorrhagic Ischaemic Total stroke
Events Incidence* Events Incidence* Events Incidence*
Men
<0.05 1539 33 12.2 112 40.5 154 56.1
0.05 to <1 1266 37 17.6 81 38.5 132 62.7
1t o<2 376 13 21.4 20 34.9 36 61.9
$2 130 5 25.2 8 46.3 13 72.4
p Valuey 0.006z 0.788 0.202
Overall 3311 88 15.7 221 39.4 335 59.7
Women
<0.05 2765 66 13.1 173 34.4 262 52.0
0.05 to <1 2720 63 12.4 174 33.9 264 51.6
1t o<2 531 8 9.3 33 39.8 46 54.9
$2 188 10 41.9x 6 27.9 19 85.7{
p Value 0.098 0.930 0.155
Overall 6204 147 13.1 386 34.4 591 52.7
*Incidence rate per 10000 person-years.
yThe p value is a test for trend with dose modelled as a continuous variable.
zFor men, risk of haemorrhagic stroke continued to rise with increasing doses <1G y( p ¼0.006).
xRisk of haemorrhagic stroke in women is higher for doses $2 Gy versus lower doses (p¼0.002).
{Risk of total stroke in women is higher for doses $2 Gy versus lower doses (p¼0.027).
Table 3 Risk factor-adjusted incidence and relative
hazards of haemorrhagic stroke by radiation exposure
Radiation
exposure (Gy) Incidence
Relative hazard
(95% CI)
Men
<0.05 11.6 Reference
0.05 to <1 17.7 1.5 (0.8 to 2.7)
1t o<2 20.2 1.7 (0.7 to 4.1)
$2 29.1 2.5 (0.8 to 7.3)
p Value* 0.009y
Women
<0.05 14.2 Reference
0.05 to <1.3 13.0 0.9 (0.6 to 1.4)
1.3 to <2.2 20.3 1.4 (0.6 to 3.7)
$2.2 48.6 3.5 (1.4 to 9.0)
p Value 0.002
Incidence rate per 10000 person-years and relative hazards are
adjusted for age, systolic blood pressure, body mass index,
diabetes, total cholesterol, cigarette smoking, alcohol drinking
and city.
*The p value is a test for trend with dose modelled as a continuous
variable. For women, a dose threshold model is used with a dose
threshold at 1.3 Gy (95% CI 0.5 to 2.3 Gy).
yFor men, risk of haemorrhagic stroke continued to rise with
increasing doses <1G y( p ¼0.004).
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Stroke incidence in atomic bomb survivorsfor cerebral haemorrhage was indistinguishable from
a 4% excess RR ( 10 to 20) for cerebral infarction.
12
Corroborating evidence also appears elsewhere,
51 0while
reports of uncertainty in the association between radia-
tion and stroke are common,
11 27 most likely due to the
extreme difﬁculties in quantifying radiation exposure in
studies that often rely on limited record keeping and
historical recall.
Given that the association between radiation and the
risk of stroke is plausible, an explanation for the associ-
ation is far from clear. At high doses (>10 Gy), there is
well-established evidence from radiotherapy patients of
direct damage in circulatory systems, predominantly the
consequence of excessive cell killing and the associated
response to cell damage. In contrast, epidemiological
studies suggest that the mechanisms associated with low-
and moderate-dose ionising radiation (<5 Gy) are
different.
16e18 More direct mechanistic derangements
that might explain an association with haemorrhagic
stroke include ﬁbrinoid necrosis of the small arteries
and arteriole, a common underlying cause for intrace-
rebral haemorrhage due to hypertension in murine
brain
28 or arteriovenous malformations in humans.
29
Fibrinoid necrosis in vessels is also preceded by proin-
ﬂammatory cytokines and observed in late cerebral
radionecrosis at radiotherapy doses <0.05 Gy.
30 Elevated
blood pressure,
19 hypertension
31 and inﬂammation (C
reactive protein and interleukin-6) among the atomic
bomb survivors
32 33 might further promote a ﬁbrinoid
necrosis link with haemorrhagic stroke. Hypertension
has a greater impact on haemorrhagic stroke incidence
than cerebral infarction.
34 In the absence of a clear
explanation for the reported ﬁndings, further study of
subclinical arteriosclerosis or biological evidences
among the AHS may provide additional insight into the
role that radiation has on promoting stroke and its
subtypes.
In the current report, several notable limitations need
to be addressed. Whether ﬁndings apply to other
ethnicities is unknown. Genetic susceptibilities may be
different. The number of haemorrhagic events is also
limited and too insufﬁcient to allow for a careful
assessment of the effect of radiation on the risk of stroke
between risk factor strata. In spite of the limitations,
ﬁndings from the AHS warrant consideration and
further study. Attractive features include the high rate of
participation between examination cycles and free access
to standardised medical care and evaluation. Measure-
ment of radiation exposure also adheres to a rigorous
system of quantiﬁcation.
14 Among large cohort studies,
the dosimetry in the AHS is unusually precise. In
conclusion, the risk of haemorrhagic stroke increases
with rising radiation exposure for both sexes. In men, it
seems to occur across the full range of radiation expo-
sures, while in women, the risk becomes apparent when
doses exceed a threshold at about 1.3 Gy. Given the
observed latency between radiation exposure and
haemorrhagic stroke in the current study, a consequence
of the expanded use of radiotherapy in younger indi-
viduals
2 could be an increased opportunity for the
development of adverse outcomes in later life.
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